Alkem Laboratories Ltd (BOM:539523)
₹ 5701.35 -20.05 (-0.35%) Market Cap: 682.30 Bil Enterprise Value: 653.78 Bil PE Ratio: 33.57 PB Ratio: 6.69 GF Score: 99/100

Q3 2022 Alkem Laboratories Ltd Earnings Call Transcript

Feb 04, 2022 / 02:30PM GMT
Release Date Price: ₹3514.35 (-0.61%)
Operator

Ladies and gentlemen, good day, and welcome to Alkem Laboratories Limited Q3 FY '22 Earnings Conference Call hosted by Motilal Oswal Financial Services Limited.

(Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Tushar Manudhane from Motilal Oswal Financial Services. Thank you, and over to you, Mr. Manudhane.

Tushar Manudhane

Thanks, [Neerav]. Welcome to 3Q FY '22 Earnings Call of Alkem Laboratories. From management side, we have Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President International Business; Mr. Yogesh Kaushal, President, Chronic Division; and Mr. Gagan Borana from Investor Relations. Over to you, Gagan, for the opening remarks.

Gagan Borana
Alkem Laboratories Limited - General Manager of IR

Thank you, Tushar. Good evening, everyone, and thank you for joining us today for Alkem Laboratories Q3 FY '22 Earnings Call. Earlier during the day, we have released our financial results and investor presentation and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot